Company intelligence / Profile preview

CanAm Bioresearch

Winnipeg, Manitoba, Canadacanambioresearch.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CanAm Bioresearch is a Canadian contract research organization specializing in medicinal chemistry services to accelerate drug discovery. The company has over 20 years of experience supporting pharmaceutical and biotech partners with custom organic synthesis, analytical chemistry, and early-stage drug development. It has contributed to advancing projects from hit identification to viable preclinical candidates for various clients. Its own pipeline includes pyridoxal 5'-phosphate analogues at the preclinical stage[1][2][5].

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Research Organization

Partnerships

Medicure (asset purchase agreement for intellectual property related to new chemical entities as of June 2024)[5]

Beyond the preview

Go deeper on CanAm Bioresearch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CanAm Bioresearch.

Explore the full profile